Manufacturer: Abnova Corporation
Pack Size | SKU | Availability | Price |
---|---|---|---|
Each of 1 | 89-934-279-Each-of-1 | In Stock | ₹ 64,426.68 |
89-934-279 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 64,426.68
GST (18%): ₹ 11,596.802
Total Price: ₹ 76,023.482
HLA-DRB1
Monoclonal
Unconjugated
Flow Cytometry (0.5-1 ug/106cells in 0.1 mL) Immunofluorescence (0.5-1 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (0.25-0.5 ug/mL) Western Blot (0.5-1 ug/mL) The optimal working dilution should be d
DRB1/FLJ76359/HLA-DR1B/HLA-DRB/HLA-DRB1*/SS1
Mouse
Protein A/G purification
RUO
3123
Human
Liquid
Flow Cytometry, Immunofluorescence, Immunohistochemistry (PFA fixed), Western Blot
SPM423
Mouse monoclonal antibody raised against native human HLA-DRB1.
In 10mM PBS.
HLA-DRB1
Activated human peripheral blood mononuclear cells.
100 μg
Primary
This monoclonal antibody does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B cells, activated T cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+T cells. It is an excellent histiocytic marker in paraffin sections producing intense staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts. Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B cell lymphoma.
Store at -20 to -80°C.Aliquot to avoid repeated freezing and thawing.
IgG2b κ